间充质干细胞
细胞疗法
干细胞
癌症研究
医学
体内
间质细胞
干细胞疗法
效力
体外
生物
细胞生物学
病理
生物技术
生物化学
作者
Mahmoud Al‐Azab,Elina Idiiatullina,Mohammed Safi,Kamal Hezam
标识
DOI:10.1016/j.biopha.2023.114356
摘要
Mesenchymal stem cells (MSCs) are multipotent stromal cells that can differentiate into a range of cell types, including osteoblasts, chondrocytes, myocytes, and adipocytes. Multiple preclinical investigations and clinical trials employed enhanced MSCs-dependent therapies in treatment of inflammatory and degenerative diseases. They have demonstrated considerable and prospective therapeutic potentials even though the large-scale use remains a problem. Several strategies have been used to improve the therapeutic potency of MSCs in cellular therapy. Treatment of MSCs utilizing pharmaceutical compounds, cytokines, growth factors, hormones, and vitamins have shown potential outcomes in boosting MSCs' stemness. In this study, we reviewed the current advances in enhancing techniques that attempt to promote MSCs' therapeutic effectiveness in cellular therapy and stemness in vivo with potential mechanisms and applications.
科研通智能强力驱动
Strongly Powered by AbleSci AI